Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy

BACKGROUND: Current treatment options for stage III non-small cell lung cancer (NSCLC) consist of different combinations of chemotherapy, surgery, radiotherapy and immunotherapy. Treatment choices are highly individual decisions, in which adverse events (AEs) are relevant for decision-making. This s...

Descripción completa

Detalles Bibliográficos
Autores principales: Iseli, Thomas, Berghmans, Thierry, Glatzer, Markus, Rittmeyer, Achim, Massard, Gilbert, Durieux, Valérie, Buchsbaum, Thomas, Putora, Paul Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487347/
https://www.ncbi.nlm.nih.gov/pubmed/32963993
http://dx.doi.org/10.1183/23120541.00010-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487347/
https://www.ncbi.nlm.nih.gov/pubmed/32963993
http://dx.doi.org/10.1183/23120541.00010-2020

Ejemplares similares